Medically reviewed by Brendan Camp, MD Hives and eczema are two of the most common skin disorders. Hives, clinically known as ...
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...
Congested skin is a common issue that occurs when dead skin cells, oil, sweat, and dirt block the pores, leading to a dull appearance or acne. Here’s what you can do to treat it.
The following is a summary of “Longitudinal integrated proteomic and metabolomic skin changes in atopic dermatitis patients ...
Researchers Shed Light on How to Predict Which Skin Cancer Patients Are Most Likely to Respond to Immunotherapy Jan. 8, 2025 — An international team of UK and US scientists discovered that the ...
What Are the Different Skin Types? There are five different skin types. Each has unique characteristics, and knowing them can help you take better care of your skin. Your skin can change over time. As ...
Read more here. Building a skin-care routine for teens and tweens can seem complicated. Puberty is often the first time kids are dealing with acne, blackheads, dry patches, and the general roller ...
1 Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy 2 Azienda Ospedaliero-Universitaria di Cagliari, Cagliari, Italy Dupilumab is a monoclonal antibody targeting ...
Both Clear and TSA PreCheck can help travelers pass through Transportation Security Administration lines quicker, while Global Entry expedites the customs process upon returning to the U.S. from ...
Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...
Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase III for Bullous Pemphigoid. According to GlobalData, Phase III drugs for Bullous Pemphigoid does not have ...